Will the new pharmaceutical lipid-aspirin complex formulation restore the once lost trust of aspirin on cardiovascular protection?

Lopez-Candales A, Norgard N. Will the new pharmaceutical lipid-aspirin complex formulation restore the once lost trust of aspirin on cardiovascular protection? Postgrad Med. 2022 08; 134(6):573-575.

View in: PubMed

subject areas

Aspirin
Cardiovascular Diseases
Humans
Lipids
Pharmaceutical Preparations
Platelet Aggregation Inhibitors
Trust

authors with profiles

Angel Lopez-Candales

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support